Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes.

Fendereski, Afsaneh; Hajizadeh, Ebrahim; Haghighat, Shahpar; Rasekhi, Aliakbar

Fendereski, Afsaneh; Hajizadeh, Ebrahim; Haghighat, Shahpar; Rasekhi, Aliakbar.

Afiliación

Fendereski A; Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Hajizadeh E; Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. hajizadeh@modares.ac.ir.
Haghighat S; Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran. haghighat@acecr.ac.ir.
Rasekhi A; Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

BMC Womens Health ; 22(1): 268, 2022 07 04.

Article en En | MEDLINE | ID: mdl-35787692

Asunto(s)

Neoplasias de la Mama; Adulto; Neoplasias de la Mama/diagnóstico; Supervivencia sin Enfermedad; Femenino; Humanos; Persona de Mediana Edad; Pronóstico; Estudios Retrospectivos; Tasa de Supervivencia

Palabras clave

Breast cancer; Disease-free survival; Mixture cure model; Molecular subtypes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: BMC Womens Health Asunto de la revista: SAUDE DA MULHER Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google